Todos Medical CEO Provides Letter to Shareholders

NEXT STORY
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
PREV STORY
NOW OPEN: Hospital for Endocrine Surgery, A Part of HCA Florida South Tampa Hospital
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunotech Laboratories, Inc. Receives Invitation to the 2018 Asia-Pacific Precision Medicine Forum

Monrovia, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. f/k/a Eco-Petroleum Solutions, ...

author_avatar
NASDAQ Market News

Coherus BioSciences Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Feb. 17, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News

Coherus BioSciences Appoints Erik Wiberg as Executive Vice President of Corporate Development

REDWOOD CITY, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today ...

author_avatar
NASDAQ Market News